Cancer drug Imfinzi improves survival chances in late-stage trial
LONDON - Lung cancer patients treated with AstraZeneca's immunotherapy Imfinzi pre- and post-surgery in a trial lived significantly longer without ...
Read moreLONDON - Lung cancer patients treated with AstraZeneca's immunotherapy Imfinzi pre- and post-surgery in a trial lived significantly longer without ...
Read moreWould you like to receive notifications on our latest news ?
© 2021 All Rights Reserved for Egyptian Gazette - Admined by Digital Transformation Management.
© 2021 All Rights Reserved for Egyptian Gazette - Admined by Digital Transformation Management.